Senseonics Holdings Inc (NYSEAMERICAN:SENS) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 4,088,887 shares, an increase of 6.2% from the November 30th total of 3,851,216 shares. Based on an average daily volume of 371,087 shares, the short-interest ratio is currently 11.0 days. Approximately 8.4% of the company’s stock are short sold.
Senseonics (NYSEAMERICAN:SENS) opened at $2.66 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics has a 52-week low of $1.26 and a 52-week high of $3.67. The stock has a market cap of $363.77 and a PE ratio of -5.32.
Senseonics (NYSEAMERICAN:SENS) last posted its quarterly earnings results on Tuesday, October 31st. The company reported ($0.13) earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of ($0.13). Senseonics had a negative net margin of 828.76% and a negative return on equity of 406.72%. The company had revenue of $2.10 million for the quarter, compared to the consensus estimate of $1.51 million. Senseonics’s revenue was up 425.0% on a year-over-year basis. research analysts anticipate that Senseonics will post -0.54 earnings per share for the current year.
In related news, major shareholder Peter J. Barris sold 139,645 shares of the firm’s stock in a transaction on Friday, December 8th. The shares were sold at an average price of $2.63, for a total transaction of $367,266.35. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 34.10% of the stock is currently owned by company insiders.
Several institutional investors have recently bought and sold shares of SENS. Renaissance Technologies LLC bought a new position in shares of Senseonics in the 1st quarter worth about $111,000. Bank of New York Mellon Corp bought a new position in shares of Senseonics in the 3rd quarter worth about $116,000. Susquehanna International Group LLP bought a new position in shares of Senseonics in the 2nd quarter worth about $155,000. Perceptive Advisors LLC bought a new position in shares of Senseonics in the 3rd quarter worth about $160,000. Finally, Citadel Advisors LLC bought a new position in shares of Senseonics in the 3rd quarter worth about $194,000. Institutional investors own 30.66% of the company’s stock.
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.